About this Event
PRESENTERS
KEYNOTE ADDRESS: High-Flow Nasal Oxygen vs Noninvasive Ventilation n Patients with Acute Respiratory Failure. The RENOVATE Randomized Clinical Trial | Dr. Israel Maia, Professor at Federal University of Santa Catarina, Brazil
Role of Asymmetry in Nasal High Flow | Dr. Stanislav Tatkov, Clinical Research Manager at Fisher & Paykel Healthcare, New Zealand
Breathing Effort During Noninvasive Respiratory Support | Dr. Annia Schreiber, Critical Care/Pulmonary Physician at St Michael’s Hospital, University of Toronto, Canada
Nasal High Flow in COPD Patients during Day and Night | Dr. Georg Nilius, professor at Kliniken Essen-Mitte, Witten/Herdecke University, Germany
CHAIR
OPENING COMMENTS: Noninvasive Respiratory Support in 2025 | Dr. Laurent Brochard, Professor, St. Michael's Hospital, University of Toronto, Canada
For an expedited check-in, please bring your Eventbrite RSVP confirmation QR code! For questions, email [email protected]!
An Industry Supported Symposium at the ATS 2025 International Conference. This evening educational program is sponsored by Fisher & Paykel Healthcare and open to all ATS 2025 International Conference attendees.
Event Venue & Nearby Stays
San Francisco Marriott Marquis | Yerba Buena 7 Ballroom, 780 Mission Street, San Francisco, United States
USD 0.00
